11th Nov 2014 09:57
LONDON (Alliance News) - Tristel PLC Tuesday said a New Zealand study had demonstrated the productivity and costs benefits of introducing the Tristel Wipes System for use on nasendoscopes in Ear Nose and Throat out-patient clinics, compared with a centralized decontamination process.
The manufacturer of infection prevention, contamination control and hygiene products said the study was undertaken by Counties Manukau Health Board in the ENT out-patients clinic, and focused on the benefits of adopting the Tristel Wipes System for the high-level disinfection of nasendoscopes. The results of the study were presented at the 3rd Asia Pacific Healthcare Forum in September 2014.
The annual cost savings of the Wipes System compared to Steris System 1, which included the reduction in staff time involved in scope reprocessing, were calculated at NZD101,950, or about GBP50,000, Tristel said. The concluding observations of the ENT department staff were that 72% strongly agreed and 28% agreed that the implementation of the Wipes System had been a success, it added.
Tristel shares were flat at 81.00 pence Tuesday morning.
By Steve McGrath; [email protected]; @stevemcgrath1
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Tristel